JLJohn George Lock

John George Lock

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John George Lock has a total of 279 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development

    by Timothy J. Mann, Therese M. Becker, Tara L. Roberts, Paul de Souza, John G. Lock

    Early-stage prostate cancer (PCa) is overwhelmingly driven by aberrant androgen receptor (AR) signalling. Accordingly, standard-of-care treatments include androgen deprivation therapy (ADT) and AR pathway inhibitors (ARPIs), with disease detection and therapy-response monitoring relying on blood-borne PSA, a product of AR transcriptional programs. Crucially, resistance to these therapies is inevitable but heterogeneous in nature; potentially driven by a diverse array of alternate signalling pathways and differentiation mechanisms such as neuroendocrine conversion. Here, we review the current standard of care for CRPC and highlight this heterogeneity - between and even within patients - which demands a new paradigm to longitudinally monitor the evolving molecular profiles of each patient to guide rational selection of targeted therapies, as well as rational patient stratification to optimise clinical trials for emerging therapies. Since solid biopsies are incompatible with extensive longitudinal profiling, we here consider recent advances in liquid biopsy-based profiling methods and assess their potential as cornerstones in a new paradigm of personalised, adaptable disease monitoring and therapeutic decision-support.

  • Open Access

    Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy

    by Christopher R. Bye, Elizabeth Qian, Katherine Lim, Maciej Daniszewski, Fleur C. Garton, Bảo C. Trần-Lê, Helena H. Liang, Tian Lin, John G. Lock, Duncan E. Crombie, et al.

    Heterogeneous and predominantly sporadic neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), remain highly challenging to model. Patient-derived induced pluripotent stem cell (iPSC) technologies offer great promise for these diseases; however, large-scale studies demonstrating accelerated neurodegeneration in patients with sporadic disease are limited. Here we generated an iPSC library from 100 patients with sporadic ALS (SALS) and conducted population-wide phenotypic screening. Motor neurons derived from patients with SALS recapitulated key aspects of the disease, including reduced survival, accelerated neurite degeneration correlating with donor survival, transcriptional dysregulation and pharmacological rescue by riluzole. Screening of drugs previously tested in ALS clinical trials revealed that 97% failed to mitigate neurodegeneration, reflecting trial outcomes and validating the SALS model. Combinatorial testing of effective drugs identified baricitinib, memantine and riluzole as a promising therapeutic combination for SALS. These findings demonstrate that patient-derived iPSC models can recapitulate sporadic disease features, paving the way for a new generation of disease modeling and therapeutic discovery in ALS.


  • Open Access

    Supplementary Table 1 from AAnet Resolves a Continuum of Spatially Localized Cell States to Unveil Intratumoral Heterogeneity

    by Aarthi Venkat, Scott E. Youlten, Beatriz P. San Juan, Carley A. Purcell, Shabarni Gupta, Matthew Amodio, Daniel P. Neumann, John G. Lock, Anton E. Westacott, Cerys S. McCool, et al.

    Primary_replicate_differentially_expressed_genes

  • Open Access

    Supplementary Table 2 from AAnet Resolves a Continuum of Spatially Localized Cell States to Unveil Intratumoral Heterogeneity

    by Aarthi Venkat, Scott E. Youlten, Beatriz P. San Juan, Carley A. Purcell, Shabarni Gupta, Matthew Amodio, Daniel P. Neumann, John G. Lock, Anton E. Westacott, Cerys S. McCool, et al.

    All tissues _differentially_expressed_genes

  • Open Access

    Data from AAnet Resolves a Continuum of Spatially Localized Cell States to Unveil Intratumoral Heterogeneity

    by Aarthi Venkat, Scott E. Youlten, Beatriz P. San Juan, Carley A. Purcell, Shabarni Gupta, Matthew Amodio, Daniel P. Neumann, John G. Lock, Anton E. Westacott, Cerys S. McCool, et al.

    Identifying functionally important cell states and structure within heterogeneous tumors remains a significant biological and computational challenge. Current clustering- or trajectory-based models are ill-equipped to address the notion that cancer cells reside along a phenotypic continuum. We present Archetypal Analysis network (AAnet), a neural network that learns archetypal states within a phenotypic continuum in single-cell data. Unlike traditional archetypal analysis, AAnet learns archetypes (AT) in a simplex-shaped neural network latent space. Using preclinical and clinical models of breast cancer, AAnet resolves distinct cell states and processes, including cell proliferation, hypoxia, metabolism, and immune interactions. Primary tumor ATs are recapitulated in matched liver, lung, and lymph node metastases. Spatial transcriptomics reveals archetypal organization within the tumor and intra-archetypal mirroring between cancer and adjacent stromal cells. AAnet identifies GLUT3 within the hypoxic AT that proves critical for tumor growth and metastasis. AAnet is a powerful tool, capturing complex, functional cell states from multimodal data.Significance:Defining critical cell states among cells that reside along a phenotypic continuum is a current biological and computational challenge. In this study, we present AAnet, a neural network that learns archetypal cell states of cancer cells. AAnet defines discrete spatially localized ATs that resolve intratumoral heterogeneity.

  • Open Access

    Figures S1-9 from AAnet Resolves a Continuum of Spatially Localized Cell States to Unveil Intratumoral Heterogeneity

    by Aarthi Venkat, Scott E. Youlten, Beatriz P. San Juan, Carley A. Purcell, Shabarni Gupta, Matthew Amodio, Daniel P. Neumann, John G. Lock, Anton E. Westacott, Cerys S. McCool, et al.

    This files contains all supplementary data supporting the development and validation of AAnet

  • Open Access

    Generative semantic multiplexing (SemaPlex) for accessible and scalable multiplexed fluorescence imaging

    by Ihuan Gunawan, Moumitha Dey, Daniel P Neumann, Felix V Kohane, Yaqing He, Erik Meijering, John G Lock

    Multiplexed fluorescence imaging enhances spatially-resolved interrogation of complex, multi-molecular cell processes that are insufficiently sampled using standard 4-5 plex imaging. To improve accessibility and scalability for multiplexed imaging, we demonstrate generative ‘Semantic Multiplexing’ (SemaPlex); a simple experimental and deep learning strategy for amplifying marker plexity several-fold by semantically unmixing multiple markers combined per imaging channel. We first characterise key determinants of SemaPlex performance, achieving precise computational multiplexing of 2-to-8 markers synthetically mixed in one channel, facilitating enhanced cell phenotype classification. We then demonstrate practical SemaPlex application, acquiring 10 markers over 4 channels (3*3-plex+1) to efficiently emulate real multiplexed labelling. This permitted accurate reconstruction of quantitative single-cell phenotypic manifolds delineating cell-cycle and mitotic dynamics, with internally validated error-detection. Finally, we exemplify use of ‘semantic guides’; additional input channels that significantly enhance multiplexing fidelity. SemaPlex makes multiple-fold increases in fluorescence imaging-plexity accessible, scalable and customisable; democratising multiplexed imaging-based interrogation of complex cell biology.

  • Open Access

    Capillary constrictions prime cancer cell tumorigenicity through PIEZO1

    by Giulia Silvani, Chantal Kopecky, Sara Romanazzo, Vanina Rodríguez, Ayan Das, Elvis Pandzic, John G. Lock, Christine L. Chaffer, Kate Poole, Kristopher A. Kilian

    Metastasis is responsible for most cancer-related deaths. However, only a fraction of circulating cancer cells succeed in forming secondary tumours, indicating that adaptive mechanisms during circulation play a part in dissemination. Here, we report that constriction during microcapillary transit triggers reprogramming of melanoma cells to a tumorigenic cancer stem cell-like state. Using a microfluidic device mimicking physiological flow rates and gradual capillary narrowing, we show that compression through narrow channels causes cell and nuclear deformation, rapid chromatin remodelling and increased calcium signalling via mechanosensor PIEZO1. Within minutes, cells upregulate transcripts associated with metabolic reprogramming and metastatic processes. Over time, this results in the stable adoption of a cancer stem cell-like state. Squeezed cells express elevated melanoma stem cell markers, exhibit increased trans-endothelium invasion and display enhanced tumorigenicity in vitro and in vivo. Pharmacological inhibition of PIEZO1 blocks this transition, while activation with Yoda1 induces the stem cell-like state irrespective of constriction. Deletion of PIEZO1 completely abolishes the constriction-induced phenotype. Together, these findings demonstrate that compressive forces during circulation reprogram circulating cancer cells into tumorigenic, stem cell-like states, primed for extravasation and metastatic colonization.


  • Open Access

    Image quality metrics fail to accurately represent biological information in fluorescence microscopy

    by Ihuan Gunawan, Richard J Marsh, Nandini Aggarwal, Erik Meijering, Susan Cox, John G Lock, Siân Culley

    Image processing methods offer the potential to improve the quality of fluorescence microscopy data, allowing for image acquisition at lower, less phototoxic illumination doses. The training and evaluation of such methods is informed and driven by full-reference image quality metrics (IQMs); however, these metrics derive from applications to natural scene images, not fluorescence microscopy images. Here we investigate the response of IQMs to common properties of fluorescence microscopy data and whether IQMs are capable of reporting the biological information content of images. We find that IQM scores are biased by image content for both raw and processed microscopy data, and that improvements in IQM values reported after processing are not reliably correlated with performance in downstream analysis tasks. As common IQMs are unreliable proxies for guiding image processing developments in biological fluorescence microscopy, image processing performance should be benchmarked according to downstream analysis success.


  • The effect of image acquisition settings and image processing on fluorescence microscopy data and downstream analysis

    by Siân Culley, Ihuan Gunawan, Susan Cox, John G Lock, Erik Meijering, Richard J Marsh, Nandini Aggarwal

    BioStudies – one package for all the data supporting a study